Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimahk trial
PACTR202308810518432Phase 4Recruiting
- Sponsor
- Dr. Abdulwasiu A. Busari
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of artemether + lumefantrine and artesunate + amodiaquine in malaria, sponsored by Dr. Abdulwasiu A. Busari. Primary endpoints: Parasite clearance time and Proportion of adverse events. Started Aug 2022; status: recruiting.
02
Drugs
artemether + lumefantrineartesunate + amodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202308810518432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202308810518432.